Centogene, Parkinson's Institute Ally on Genetic Screening

Jan 09, 2017

|

NEW YORK (GenomeWeb) – The Parkinson's Institute and Clinical Center announced on Friday a collaboration with Germany's Centogene on panel-based genetic screening for a US patient cohort.

Under the partnership, patients will be screened using a large, customized panel to characterize genetic variants associated with development and treatment of Parkinson's disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Centogene, Parkinson's Institute Ally on Genetic Screening

To read the full story....

Breaking News

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

What's Popular?

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Roche Renews Agreement to Distribute Sysmex Hematology Products

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Rhinostics Licenses Procter & Gamble Nasal Swab for COVID-19 Testing

Sponsorships